A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

NCT06357377 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Tumor of CNS
Pediatric Tumor of Brain
Diffuse Midline Glioma, H3 K27M-Mutant
Pediatric Tumor of Brain Stem
Pineocytoma
Choroid Plexus Carcinoma, Childhood
Spinal Cord Tumor
High Grade Glioma

Interventions

DRUG: NEO100

Sponsor

Neonc Technologies, Inc.